US Medical Aesthetic Devices Market (By Type of Device: Energy-based Aesthetic Device, Non-energy-based Aesthetic Device; By Application: Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Tattoo Removal, Breast Augmentation, Other Applications; By End User: Hospital & Clinics, Home Settings) - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2032

The US medical aesthetic devices market size was exhibited at USD 16.71 billion in 2022 and is projected to hit around USD 42.38 billion by 2032, growing at a CAGR of 9.75% during the forecast period 2023 to 2032

US Medical Aesthetic Devices Market Size 2023 To 2032

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaways

  • On the basis of type of device, the non-energy-based aesthetic device segment accounted for 79.40% of revenue share in 2022.
  • On the basis of application, the skin resurfacing and tightening segment held the highest market share in 2022.
  • On the basis of end-user, the hospitals and clinics segment accounted for the biggest market share in 2022.

US Medical Aesthetic Devices Market Overview

Medical Aesthetic Devices are used to overcome flaws in a person's physical appearance. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) estimates that in the United States in 2021, 1.4 million surgical and non-surgical operations were carried out. The top 5 cosmetic surgical procedure in the United States includes Facelift surgeries, Liposuction, Breast Augmentation, Nose reshaping, and eyelid surgery. The demand for aesthetic treatment in developing countries is growing due to the urge to look young and fit. 

The aesthetic method such as liposuction, nose reshaping, and Botox injection are gaining consumer attention. Skin-tightening and non-invasive fat technologies have recently established out a new niche in the medical aesthetics market. The key factors enhancing the growth of the U.S. Aesthetic Medical Device market are a surge in the prevalence of facial deformities and congenital teeth, enhancement in demand for non-invasive surgeries, an increase in the number of cosmetic surgeries, and advancement in aesthetic devices.

COVID -19 Impact:

Manufacturers of cosmetic and aesthetic devices were ordered to cease manufacturing and supply because of the global lockdown that was implemented at the start of the COVID-19 pandemic. The pandemic had a significant impact on both invasive and non-invasive aesthetic operations, including the market for body contouring. For instance, according to Bloomberg, non-invasive fat removal, injectable lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid operations, laser skin resurfacing, rhinoplasty, and tummy tucks, saw a 20% decline in first half of 2020. However, according to The International Society of Aesthetic Plastic Surgery, by the end of 2020, the desire and demand for aesthetic procedures like body contouring had dramatically grown and had surpassed pre-pandemic levels.

US Medical Aesthetic Devices Market Scope

Report Coverage Details
Market Size in 2022 USD 16.71 Billion
Market Size by 2032 USD 42.38 Billion
Growth Rate from 2023 to 2032 CAGR of 9.75%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Type of Device, By Application, By End User

US Medical Aesthetic Devices Market Dynamics 


The rising prevalence of obesity, increased awareness of cosmetic treatments, expanding use of minimally invasive devices, and technical developments in devices are some factors that are fueling the market's growth.

The rise in the choice of minimally invasive and non-invasive cosmetic surgeries

  • Compared to standard surgical treatments, minimally invasive/nonsurgical methods provide a variety of benefits, such as quicker recovery times and less pain and scarring. For instance, according to the American Society of Plastic Surgeons, Plastic Surgery Statistics Report 2020, there were 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures performed in the United States in 2020.

High Awareness of cosmetic operations and rising obesity rates

  • A person's appearance can be improved without surgery using medical aesthetic devices. These goods, which also use the name "cosmetic surgery devices," include a wide range of things including laser hair removal equipment, microdermabrasion equipment, photo rejuvenation systems, cellulite reduction equipment, body contouring equipment, breast implants, and others. Although the geriatric population is mostly driving the need for aesthetic operations, younger people are also favoring the usage of aesthetic procedures, which is driving the demand for aesthetic equipment. 
  • WHO estimates that the prevalence of obesity has risen since 1975 and that roughly 30% of people worldwide are obese. A primary underlying cause of obesity, illness, and disability is sedentary behavior. All developed and emerging nations have high levels of physical inactivity.


High cost and side effects of the aesthetic surgery device

  • The risk of potential side effects comes along with technological innovation in various cosmetic procedures. A few commonly occurring side effects in patients undergoing breast augmentation or facelift includes hematoma. Another side effect that occurs after a tummy tuck or body fat reduction is seroma, which appears in 15-30% of patients. Despite several therapeutic and aesthetic applications of botox, the expense and side effects are expected to hinder the market growth. 


Accessibility to technologically advanced and user-friendly products

  • Non-invasive fat-freezing body contouring system has led to technologically improved products. The market for medical aesthetic devices will be boosted by rising investments in research and development for the launch of new products. For instance, Cynosure introduced the Elite iQ platform in the US, European, and Australian markets in June 2020 for laser hair removal and skin rejuvenation applications.

The breast implants sub-segment is Expected to show rapid grow in the implants segment of the market

  • The International Society of Aesthetic Plastic Surgery Report 2020 states that 371,997 breast augmentation operations were performed in the US in 2016. The market is anticipated to grow at a modest rate over the projected period as a result of its prevalence among celebrities and anyone seeking to enhance their outer appearance. 

Type of Device Insights

Based on the type of device, the U.S. Aesthetic Medical Device Market is segmented into Energy-based Aesthetic Devices and Non-energy-based Aesthetic Devices. The Energy-based Aesthetic Device is further segmented into Laser-based Aesthetic Devices, Radiofrequency (RF)-based Aesthetic Devices, Light-based Aesthetic Devices, and Ultrasound Aesthetic devices.

US Medical Aesthetic Devices Market Share, By Type of Device, 2021 (%)

The Non-energy-based aesthetic device is segmented into botulinum toxin, dermal fillers and aesthetic threads, microdermabrasion, and others. In 2022 the implants (non-energy based) sector accounted for 79.40% of the aesthetic medicine market, because of rising demand for procedures like breast augmentation and face surgeries like rhinoplasty and blepharoplasty. In June 2020, JUVÉDERM® VOLUMATM XC of Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), was granted approval by the FDA for the augmentation of the chin area in people over the age of 21.

Application Insights

Based on application, the largest market share in 2022 is held by the skin resurfacing and tightening segment. This is due to the large population undergoing cosmetic treatment which includes skin resurfacing, and diminishing fine lines, wrinkles, and dark spots. The face aesthetics segment's revenue in 2020 was primarily driven by the growing demand for non-invasive cosmetic treatments and facial aesthetic operations. During the projected period, the market's feminine rejuvenation category is anticipated to grow at the largest CAGR. The most effective procedure for fat removal is liposuction. It removes up to 5 liters of fat from the procedure. 

For instance, according to the American Society of Plastic Surgeons (ASPS), liposuction ranked second among procedures performed in the U.S. following breast augmentation, with 211,067 procedural volumes in 2020. During the projection period, non-surgical skin tightening is anticipated to see considerable market growth of 15.0%. This is due to the body's synthesis of collagen increasing with age but elastin decreasing, which causes fine lines and dull, sagging skin to appear.

End-User Insights

Based on the end-user, the largest share of the medical aesthetic market is estimated to be accounted for by the hospitals and clinics segment, in 2022. The increased demand for minimally invasive cosmetic operations and the emergence of medical spas and clinics with infrastructure fully equipped with technologically advanced instruments/devices and skilled professionals are the two main drivers of this segment's growth.

Recent Developments

  • In June 2022, Cynosure launches the PicoSure Pro device, a next-generation aesthetic laser device. PicoSure Pro is the first and only 755nm picosecond laser that has received FDA clearance. It uses pressure rather than heat to deliver energy in a trillionth of a second, offering all skin types safe and effective treatments for hyperpigmentation and skin rejuvenation. 
  • In November 2021, an agreement was signed between NanoPass Technologies and Aesthetic Management Partners (AMP) to commercialize NanoPass’s MicronJet 600 intradermal delivery device in the United States.
  • In May 2021, Soliton, a medical device firm, is acquired by Allergen Aesthetics. Due to the acquisition, Allergan have access to Soliton's RESONIC rapid acoustic pulse (RAP) technology. RESONIC got the US Food and Drug Administration's 510(k) certification. It is a non-invasive gadget designed to temporarily improve cellulite appearance.
  • In March 2021, Longer-lasting neuromodulator drug candidate DaxibotulinumtoxinA for Injection (DAXI), a Botulinum Toxin Type A formulated with a novel peptide excipient or combined treatment of glabellar, dynamic forehead, and lateral canthal lines was introduced by Revance Therapeutics, Inc. 
  • In August 2020, NuEra Tight with FocalRF technology has been invented by Lumenis Ltd., the leading energy-based medical device business for cosmetic, surgical, and ophthalmic purposes.

Artificial Intelligence (AI) Software Market Companies

  • Cynosure 
  • Alma Lasers
  • Lumenis Inc.
  • Bausch Health Companies Inc. (Solta Medical Inc.) 
  • Abbvie
  • Lumenis Ltd.
  • Dentsply Sirona, Inc.
  • Dentsply Sirona, Inc.
  • PhotoMedex, Inc.
  • Straumann

Segments Covered in the Report 

(Note*: We offer reports based on sub-segments as well. Kindly, let us know if you are interested)

By Type of Device 

  • Energy-based Aesthetic Device 
    • Laser-based Aesthetic Device
    • Radiofrequency (RF)-based Aesthetic Device
    • Light-based Aesthetic Device
    • Ultrasound Aesthetic Device
  • Non-energy-based Aesthetic Device
    • Botulinum Toxin
    • Dermal Fillers and Aesthetic Threads
    • Microdermabrasion
    • Other

By Application 

  • Skin Resurfacing and Tightening
  • Body Contouring and Cellulite Reduction
  • Hair Removal
  • Tattoo Removal
  • Breast Augmentation 
  • Other Applications

By End User 

  • Hospital & Clinics 
  • Home Settings

Frequently Asked Questions

What is the US medical aesthetic devices market size?
The US medical aesthetic devices market size was accounted at USD 16.71 billion in 2022 and it is expected to reach around USD 42.38 billion by 2032.
What will be the CAGR of US medical aesthetic devices market?
The US medical aesthetic devices market is poised to grow at a CAGR of 9.75 % from 2023 to 2032.
Who are the prominent players operating in the US medical aesthetic devices market?
The major players operating in the US medical aesthetic devices market are Cynosure, Alma Lasers, Lumenis Inc., Bausch Health Companies Inc. (Solta Medical Inc.), Abbvie, Lumenis Ltd., Dentsply Sirona, Inc., Dentsply Sirona, Inc., PhotoMedex, Inc., Straumann and Others.
Which are the driving factors of the US medical aesthetic devices market?
The driving factors of the US medical aesthetic devices market are the rise in the choice of minimally invasive and non-invasive cosmetic surgeries, High Awareness of cosmetic operations and rising obesity rates.


   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 6000


No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Get a Sample